Gates Package — page 208

G1 - NIAID DIR collaborative agreements active between June 1 2016 and Dec 13 2023 Reference# I Agreement Type Effective Date Expiration Dz External Parties *Lead Pl GLAXO WELLCOME, INC. (now GlaxoSmithKline; 2016-0073 CRADA 4/8/2016] 4/8/2019] GSK) Helene Rosenberg} 2016-0076 Letter of Intent/MOU 1/29/2016} Wayne State University [US] Michael Otto 2016-0102 Letter of Intent/MOU 2/5/2016} Georgetown University Michael Otto Merck & Co., Inc. (currently Merck, Sharp, and 2016-0103 Research Collaboration Agreement 9/6/2016} 5/16/2019}Dohme) Jeffrey Cohen 2016-0107 Research Collaboration Agreement 8/23/2016] 8/23/2019] University of California-San Francisco (UCSF) Byron Caughey 2016-0115 Research Collaboration Agreement 5/13/2016] 5/13/2019]Sigmovir Biosystems Inc [US] Jeffrey Cohen University of Oxford (incl Isis Innovation, The 2016-0119 Research Collaboration Agreement 5/12/2016] 5/12/2017}|Chancellor, Masters and Scholars Vincent Munster 2016-0123 Research Collaboration Agreement 8/26/2016] 8/26/2027] HVIDOVRE HOSPITAL Patrizia FARCI 2016-0129 Research Collaboration Agreement 6/16/2016] 6/16/2019] Adaptive Therapeutics [US] Patrick Duffy 2016-0152 CTA - Clinical Trial Agreement 8/16/2016| PepTcell Limited (renamed SEEK 12/1/10) [ GB] Mathew Memoli 2016-0152 CTA - Clinical Trial Agreement 8/16/2016} PepTcell Limited (renamed SEEK 12/1/10) [ GB] Mathew Memoli 2016-0152 CTA - Clinical Trial Agreement 8/16/2016| PepTcell Limited (renamed SEEK 12/1/10) [ GB] Mathew Memoli 2016-0170 Letter of Intent/MOU 3/4/2016} Thomas Jefferson University Michael Otto 2016-0186 Research Collaboration Agreement 3/22/2016] 3/22/2019]Yale University School of Medicine [US] Kirk Druey 2016-0188 CRADA 1/5/2017} 1/5/2020} GlaxoSmithKline (GSK) Patrick Duffy Biomedical Advanced Research and Development 2016-0200 Research Collaboration Agreement 3/24/2016} 3/24/2017] Authority (BARDA) (DHHS), Sanofi US Services Inc. Biomedical Advanced Research and Development 2016-0200 Research Collaboration Agreement 3/24/2016] 3/24/2017|Authority (BARDA) (DHHS), Sanofi US Services Inc. 2016-0206 CRADA 7/6/2016] 7/7/2020) GlaxoSmithKline LLC (GSK) Sangamo Therapeutics (formerly Sangamo 2016-0212 Research Collaboration Agreement 3/2/2016} BioSciences, Inc) [US] Harry Malech Biomedical Advanced Research and Development 2016-0216 CTA - Clinical Trial Agreement 6/9/2016 6/9/2019} Authority (BARDA) (DHHS), Sanofi US Services Inc. }|Kanta Subbarao Biomedical Advanced Research and Development 2016-0216 CTA - Clinical Trial Agreement 6/9/2016} 6/9/2019} Authority (BARDA) (DHHS), Sanofi US Services Inc. }|Kanta Subbarao 2016-0218 Research Collaboration Agreement 7/10/2016] 7/10/2019}RedHill Biopharma Ltd. [IL] Peter Jahrling 2016-0222 CRADA 10/17/2016] 10/16/2021|Amgen Inc. David Sacks 2016-0224 Research Collaboration Agreement 3/12/2016] 3/21/2018|Genentech, Inc. Ronald Germain